1.Acid and Bile Reflux in Children with Gastroesophageal Reflux Disease
ju-rong, WEI ; shao-ming, ZHOU ; hong-ying, LUO ; da-ming, BAI ; cheng-rong, LI
Journal of Applied Clinical Pediatrics 2004;0(09):-
Objective To investigate the role of acid and bile reflux in children with gastroesophageal reflux disease (GERD) and to evaluate the significance of detecting acid and bile reflux in diagnosing GERD in children.Methods Using ambulatory 24 h pH mo-(nitoring) and bilirubin monitoring technique, we simultaneously assessed the changes of intraesophageal pH and bile reflux in 23 subjects (including 11 healthy controls and 12 patients with GERD).Results The time of esophageal acid exposure (pH
2.Establishment and application of a high-throughput drug screening model based on COL1A1 promoter for anti-liver fibrosis.
Shuang-Shuang ZHAO ; Ju-Xian WANG ; Yu-Cheng WANG ; Rong-Guang SHAO ; Hong-Wei HE
Acta Pharmaceutica Sinica 2015;50(2):169-173
For screening the potential drugs as anti-liver fibrosis candidates, we established a high- throughput drug screening cell model based on COL1A1 promoter. The activity of COL1A1 promoter and luciferase reporter gene can be elevated by TGF-β1, and inhibited by candidate drugs. We constructed a recombined plasmid with COL1A1 promoter and luciferase reporter gene pGL4.17, the activity of COL1A1 promoter was reflected by fluorescence intensity. COL1A1 promoter activity was detected by Dual-Luciferase Reporter Assay System, it came that the relative luciferase activity of COL1A1 promoter was 15.98 times higher than that of control group induced by TGF-β1, showing the recombined plasmid could be used in cell model. The recombined plasmid was transfected into human hepatic stellate cells LX2, detected the effect of potential drugs, and obtained a stable expression system through stable transfection and monoclonal cell culture. A sample which could reduce COL1A1 promoter activity signally by our cell model, decreased collagen I mRNA and protein expression detected by real-time RT-PCR and Western blotting. It indicates this novel cell model can be used in high-throughput drug screening of potential anti-liver fibrosis drugs.
Collagen Type I
;
genetics
;
Drug Evaluation, Preclinical
;
methods
;
Genes, Reporter
;
Hepatic Stellate Cells
;
High-Throughput Screening Assays
;
Humans
;
Liver Cirrhosis
;
drug therapy
;
Luciferases
;
Plasmids
;
Promoter Regions, Genetic
;
RNA, Messenger
;
Transfection
;
Transforming Growth Factor beta1
;
pharmacology
3.A child with gastric stromal sarcoma.
Shao-ming ZHOU ; Lai-bao SUN ; Hong-ying LUO ; Ju-rong WEI ; Da-ming BAI
Chinese Journal of Pediatrics 2004;42(1):73-73
Child, Preschool
;
Female
;
Humans
;
Sarcoma
;
diagnosis
;
surgery
;
Stomach Neoplasms
;
diagnosis
;
surgery
;
Stromal Cells
;
pathology
5.The development of a blood pressure monitor based on oscillometric method.
Li-yu HUANG ; Wei-rong WANG ; Jing-zhi CHENG ; Feng-chi JU
Chinese Journal of Medical Instrumentation 2002;26(4):253-255
This paper describes a type of blood pressure monitor we have developed using 8031 chip microprocessor based on oscillometric method and the designs of hardware and software. Comparing the measurement results of oscillometric method with that of direct invasive measurement method, we find that the monitor is very useful in clinical applications. Finally in the paper, some improvements that can be made in the monitor are proposed.
Algorithms
;
Blood Pressure Monitoring, Ambulatory
;
instrumentation
;
Equipment Design
;
Humans
;
Microcomputers
;
Oscillometry
;
Software Design
6.Digestive system manifestations in children infected with novel influenza A (H1N1) virus.
Ju-Rong WEI ; Zhi-Wei LU ; Zheng-Zhen TANG ; He-Ping WANG ; Yue-Jie ZHENG
Chinese Journal of Contemporary Pediatrics 2010;12(10):793-795
OBJECTIVETo study the digestive system manifestations in children infected with novel influenza A (H1N1) virus.
METHODSA prospective study of 153 children infected with novel influenza A (H1N1) virus in Shenzhen Children's Hospital from November 2009 to January 2010 was conducted. The clinical features and outcomes of 69 children with digestive system manifestations were analyzed.
RESULTSThe children presenting with digestive system manifestations accounted for 45% (69 cases) in the 153 hospitalized children with novel influenza A (H1N1) infection. Gastrointestinal manifestations were observed in 50 cases (33%) and liver function abnormality in 19 cases (12%). The incidence rate of coma, neurological complications, increase in creative kinase level, ICU admission, and death in the patients with digestive system manifestations were significantly higher than those without digestive system manifestations (P<0.05). In the 69 patients with digestive system manifestations, 5 died from severe complications and 64 recovered fully. Gastrointestinal manifestations disappeared through 1 to 3 days and abnormal liver function recovered through 4 to 7 days.
CONCLUSIONSDigestive system manifestations are common in children infected with novel influenza A (H1N1) virus. Neurological system involvements are more common in the patients with digestive system manifestations than those without.
Adolescent ; Child ; Child, Preschool ; Digestive System Diseases ; etiology ; therapy ; Female ; Humans ; Infant ; Influenza A Virus, H1N1 Subtype ; Influenza, Human ; complications ; Male ; Prospective Studies
7.The second stage revision for infected total hip arthroplasty using antibiotic-loaded cement prosthesis.
Wei WEI ; Bo-Long KOU ; Rong-Sen JU ; Hou-Shan LÜ
Chinese Journal of Surgery 2007;45(4):246-248
OBJECTIVETo investigate the effect of two-stage revision for infected total hip arthroplasty (THA) using antibiotic-loaded cement prosthesis.
METHODSFrom June 1999 to October 2004, 14 patients who admitted for infected primary total hip arthroplasty surgeries were performed revision surgery with antibiotic-loaded cement prosthesis in two-stage. The mean Harris score of pre-operation was 23. In the first stage operation, the following steps were performed, complete debridement, removal of infected prosthesis, implantation of cement spacer with antibiotics, treatment involved concomitant administration of 3 weeks of intravenous (IV) and 1 month of oral. After 6 months, antibiotic-loaded prosthesis was implanted in the second stage.
RESULTSThe mean follow-up was 18 months (7 - 26 months), no recurrent infection occurred in all 14 patients. The mean post-operation Harris score was 70.
CONCLUSIONSThe success of the protocol to control the delayed infection after THA are complete debridement, enough interval and using antibiotic-loaded cement prosthesis in two stage revision.
Adult ; Aged ; Anti-Bacterial Agents ; therapeutic use ; Arthroplasty, Replacement, Hip ; adverse effects ; Bone Cements ; Female ; Follow-Up Studies ; Hip Prosthesis ; Humans ; Male ; Middle Aged ; Prosthesis-Related Infections ; diagnosis ; etiology ; surgery ; Reoperation
8.Discussion on the application principle of tuina manipulations for lumbar intervertebral disc herniation in Chinese literatures in recent 30 years
Yu-Rong LI ; Fu-Chong LAI ; Wen-Hao LI ; Ji-Zheng LI ; Jia-Jia WEI ; Wei-Qiang ZHANG ; Tao JIA ; Peng-Fei LI ; Ju-Bao LI
Journal of Acupuncture and Tuina Science 2019;17(4):270-277
Objective: To discuss the application principle in tuina manipulation for lumbar intervertebral disc herniation (LIDH) in Chinese literatures published in recent 30 years. Methods: The three major Chinese databases, Wanfang Academic Journal Full-text Database (Wanfang), Chongqing VIP Database (CQVIP) and China National Knowledge Infrastructure (CNKI), were searched to collect the studies of tuina manipulations in treatment of LIDH published in recent 30 years. Clustering analysis was applied to analyze the top 20 tuina manipulations for LIDH. Results: The top 20 most frequently used manipulations for LIDH were Gun-rolling, Rou-kneading, Dian-digital pressing, oblique Ban-pulling, An-pressing, Tanbo-plucking, Bashen-pulling and extending, horizontal Tui-pushing, Na-grasping, Anrou-pressing and kneading, Dou-shaking, Yao-rocking, Ca-scrubbing, Pai-patting, post-extension Ban-pulling, Mo-rubbing, Zhen-vibrating, Nie-pinching, fist-back Ji-tapping, and dorsal Shen-extending methods. The involved manipulations can be divided into two categories by the treated body areas. One category is applied to the soft tissues, including Gun-rolling, Rou-kneading, Dian-digital pressing, An-pressing, Tanbo-plucking, horizontal Tui-pushing, Na-grasping, Anrou-pressing and kneading, Ca-scrubbing, Pai-patting, Mo-rubbing, Zhen-vibrating, Nie-pinching, and fist-back Ji-tapping methods. The other category is applied to bones and joints, including oblique Ban-pulling, Bashen-pulling and extending, Dou-shaking, Yao-rocking, post-extension Ban-pulling, and dorsal Shen-extending methods. Conclusion: Based on the treated body area, the tuina manipulations applied to treat LIDH are predominated by the ones performed on soft tissues, assisted by those on bones and joints. From the way of force exertion, the involved manipulations are majorly the swinging methods, followed by squeezing and pressing ones. The manipulations applied to bones and joints are predominated by the Ban-pulling ones, followed by the Bashen-pulling and extending ones.
9.Preparation of cisplatin multivesicular liposomes and release of cisplatin from the liposomes in vitro.
Chao-ju XIAO ; Xian-rong QI ; Waer AINI ; Shu-li WEI
Acta Pharmaceutica Sinica 2003;38(2):133-137
AIMTo prepare cisplatin multivesicular liposomes with high encapsulation efficiency and sustained-release character, and compare the release characteristics with conventional liposomes prepared by reverse-phase evaporation method.
METHODSCisplatin multivesicular liposomes were prepared using multiple emulsion method. The concentrations of cisplatin and lipids in the liposomes were measured by flameless atomic absorbance spectroscopy (FAAS) and phosphalipid enzyme reagent method, respectively. The encapsulation efficiency, size and release of the cisplatin from the liposomes were studied in vitro.
RESULTSThe mean diameter of cisplatin multivesicular liposomes was (16.6 +/- 1.0) micron. The encapsulation efficiency of cisplatin was more than 80%. The release profile in vitro fitted with a first-order equation. The releasing t1/2 of cisplatin multivesicular liposomes is 37.7 h, which is 8.4 that of conventional liposomes. Co-membrane stabilizer has remarkable stabilizing effect on the multivesicular liposomal membrane confirmed by differential scattering calorimetry (DSC).
CONCLUSIONThe cisplatin multivesicular liposomes showed high encapsulation efficiency and sustained-release character.
Antineoplastic Agents ; administration & dosage ; analysis ; Cisplatin ; administration & dosage ; analysis ; Delayed-Action Preparations ; Drug Carriers ; Drug Delivery Systems ; Liposomes ; Particle Size ; Technology, Pharmaceutical ; methods
10.Inhibitory effect of RNA interference on chronic myeloid leukemia bcr/abl oncogene expression.
Xiao-xia MA ; Chun WANG ; Ju WEI ; You-wen QIN ; Shi-ke YAN ; Yan-rong GAO ; Qi CAI
Chinese Journal of Hematology 2005;26(6):359-362
OBJECTIVETo investigate the inhibitory effect of RNA interference on chronic myeloid leukemia (CML) bcr/abl oncogene expression.
METHODSThe small interference RNAs (siRNAs) were synthesized in vitro. K562 cells stably expressing bcr/abl gene were transfected with the siRNA by electroporation, both the non-transfected cells and non-specific siRNAs transfected cells were taken as controls. The enhanced green fluorescent protein (EGFP) plasmid was used as positive control and the transfection efficiency was detected by flow cytometry. Inhibitory effect of siRNAs was demonstrated by real-time quantitative RT-PCR and Western blots. Cell proliferation was measured by MTT assay and apoptosis by Annexin V-FITC assay.
RESULTSThe transfection efficiency was about 70%. The synthesized siRNAs inhibited CML bcr/abl oncogene expression at both mRNA and protein levels. siRNAs could inhibit K562 cell proliferation to 47% and 56% at 24 h and 48 h after transfection, respectively, and induce cell apoptosis from 1.00% in control group to 15.05% and 19.4% at 24 h and 48 h respectively.
CONCLUSIONAt the cell level, inhibition of CML bcr/abl oncogene expression by chemically synthesized siRNAs provides the new method for anti-leukemia study.
Apoptosis ; genetics ; Cell Proliferation ; Fusion Proteins, bcr-abl ; genetics ; Humans ; K562 Cells ; RNA, Small Interfering ; Transfection